Clear Perspective Advisors’s Biogen BIIB Stock Holding History

Clear Perspective Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-316	Closed	-$74K	–	153
2019 Q2	$74K	Buy	+316	New	+$73K	0.05%	156
2018 Q3	–	Sell	-190	Closed	-$55K	–	169
2018 Q2	$55K	Buy	190 +25	+15%	+$7.03K	0.04%	239
2018 Q1	$45K	Hold	165	–	–	0.03%	250
2017 Q4	$53K	Hold	165	–	–	0.04%	228
2017 Q3	$52K	Hold	165	–	–	0.04%	230
2017 Q2	$45K	Hold	165	–	–	0.04%	229
2017 Q1	$45K	Hold	165	–	–	0.03%	218
2016 Q4	$47K	Buy	+165	New	+$48.9K	0.03%	205

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Clear Perspective Advisors's BIIB Position: Q3 2019 in Review

Clear Perspective Advisors sold out of Biogen (BIIB) in Q3 2019, closing a stake of 316 shares — an estimated $74K sold.

Clear Perspective Advisors first reported a position in BIIB in Q4 2016 and held it in 8 quarters. The position peaked at $74K in Q2 2019. 989 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

Clear Perspective Advisors reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
Clear Perspective Advisors sold 316 Biogen shares in Q3 2019, an estimated $74K.
Clear Perspective Advisors first reported a position in Biogen in Q4 2016 and held it in 8 quarters.
Clear Perspective Advisors's Biogen position peaked at $74K in Q2 2019.
989 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Clear Perspective Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.